rs61761074
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among them, rs61761074 demonstrated a significant correlation with allele frequency in non-small-cell lung cancer (NSCLC).
|
26648033 |
2015 |
rs61764370
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We have reported the analysis performed on the role of the polymorphism located in the KRAS-LCS (rs61764370) which is involved in the disruption of the let-7 complementary site in NSCLC patients enrolled within the TAILOR trial, a randomised trial comparing erlotinib versus docetaxel in second line treatment.
|
26573509 |
2015 |
rs61764370
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Recently, a variant allele in the 3'UTR of the KRAS gene (rs61764370 T>G) was shown to be associated with an increased risk for developing non-small cell lung cancer, as well as ovarian cancer, and was most enriched in ovarian cancer patients from hereditary breast and ovarian cancer families.
|
20676756 |
2011 |
rs727503108
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
|
23548132 |
2013 |
rs727503108
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
|
20926413 |
2011 |
rs121913238
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia.
|
19047918 |
2009 |
rs727503108
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
rs112445441
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
|
18794081 |
2008 |
rs112445441
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
|
18794081 |
2008 |
rs121913238
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
|
18794081 |
2008 |
rs121913240
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
|
18794081 |
2008 |
rs121913240
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
|
18794081 |
2008 |
rs121913240
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.
|
17062680 |
2006 |
rs727503108
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
rs112445441
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
|
15696205 |
2005 |
rs121913240
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
|
15696205 |
2005 |
rs112445441
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs112445441
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913238
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913240
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913240
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs397517040
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397517040
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs727503106
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121913535
|
|
|
0.710 |
GeneticVariation |
BEFREE |
KRAS mutations were found in 18 (7.2%) patients (15 in adenocarcinoma, 2 in squamous cell carcinoma and one in NSCLC-not otherwise specified), including an uncommon substitution G13C.
|
24040454 |
2013 |